Research
Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d1672 (Published 30 March 2011) Cite this as: BMJ 2011;342:d1672Data supplement
Web Extra
Extra material supplied by the author
Files in this Data Supplement:
- Data Supplement - Webtables 1 and 2
Related articles
- News Published: 09 November 2006; BMJ 333 doi:10.1136/bmj.39024.405602.DB
- Research Published: 30 June 2009; BMJ 338 doi:10.1136/bmj.b2376
See more
- Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICEBMJ May 19, 2023, 381 p1146; DOI: https://doi.org/10.1136/bmj.p1146
- David Oliver: What the plan for social care omittedBMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227
- Stroke: “striking reductions” are seen in number of people with symptoms seeking helpBMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406
- NICE recommends implantable monitor to identify atrial fibrillation after strokeBMJ January 14, 2020, 368 m133; DOI: https://doi.org/10.1136/bmj.m133
- Thrombectomy can be considered up to 24 hours after onset of stroke, says NICEBMJ November 23, 2018, 363 k4995; DOI: https://doi.org/10.1136/bmj.k4995
Cited by...
- Cost-Effectiveness of Intensifying Lipid-Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
- CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines
- Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model
- Quantifying the utility of taking pills for preventing adverse health outcomes: a cross-sectional survey
- Quantifying the Utility of Taking Pills for Cardiovascular Prevention
- Patient-Accessible Tool for Shared Decision Making in Cardiovascular Primary Prevention: Balancing Longevity Benefits Against Medication Disutility
- Who Needs Laboratories and Who Needs Statins?: Comparative and Cost-Effectiveness Analyses of Non-Laboratory-Based, Laboratory-Based, and Staged Primary Cardiovascular Disease Screening Guidelines
- Long-term prediction of major coronary or ischaemic stroke event in a low-incidence Southern European population: model development and evaluation of clinical utility
- Contrast Delay on Perfusion CT as a Predictor of New, Incident Infarct: A Retrospective Cohort Study
- Advances in Health Policy and Outcome 2010-2011